Valiglurax
Valiglurax (VU2957), also known as VU0652957 and VU2957, is a potent, selective, CNS penetrant, and orally bioavailable mGlu4 PAM. VU2957 possessed attractive in vitro and in vivo pharmacological and DMPK properties across species. VU2957 was evaluated as a preclinical development candidate for the treatment of Parkinson’s disease.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
329.28
Molecular Formula
C16H10F3N5
Notes
Research use only, not for human use.
Receptor
GluR
CAS Number
1976050-09-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
